CSIMarket
 


Usana Health Sciences Inc   (USNA)
Other Ticker:  
 


Usana Health Sciences Inc 's EBITDA Margin by quarter

Trends, Rankings, Statistics



USNA EBITDA Margin (Dec 30 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jul 01 2023)
II. Quarter
(Apr 01 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change -2.72 % -8.55 % -9.88 % -9.04 % 5.8 %
Seq. Revenue Change 4.19 % -10.53 % -4.02 % 8.72 % -2.05 %
Revenue In Millions $221.76 $212.84 $237.88 $247.84 $227.97
EBITDA Margin 13.38 % 11.2 % 12.64 % 12.84 % 11.46 %
EBITDA Margin Total Ranking # 1315 # 2104 # 2049 # 1963 # 2360
EBITDA In Millions $29.67 $23.85 $30.07 $31.83 $26.13
Y / Y EBITDA Change 13.56 % -10.79 % 12.51 % 5.83 % -33.72 %
Seq. EBITDA Change 24.42 % -20.71 % -5.52 % 21.84 % -2.26 %


Commenting fourth Quarter 2023 EBITDA Margin
Usana Health Sciences Inc EBITDA grew by 24.42 % in IV. Quarter sequentially to 30 millions, while Revenue increased by 4.19 %, this led to improvement in the company's EBITDA Margin to 13.38 %, EBITDA Margin remained below Usana Health Sciences Inc average.

Observing fourth quarter 2023 results within Legal Cannabis industry only one other company has achieved higher EBITDA Margin. While EBITDA Margin total ranking has impoved so far to 1315, from total ranking in previous quarter at 2104.
Learn about Operating Margin
USNA's EBITDA Margin fourth quarter 2023 Company Ranking
Within: No.
Legal Cannabis Industry # 2
Consumer Non Cyclical Sector # 45
Overall # 1315

EBITDA Margin Statistics
High Average Low
19.23 % 15.51 % 10.13 %
(Jun 29 2013)   (Jul 02 2022)




Other EBITDA Margin Profitability Ratios
USNA's Cumulative EBITDA Margin
Legal Cannabis Industry EBITDA Margin Trends and Statistics
Consumer Non Cyclical Sector EBITDA Margin Statistics
EBITDA Margin Profitability Trends for overall market
USNA's EBITDA Margin Profitability versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking EBITDA Margin
Lowest Ranking EBITDA Margin
EBITDA Margin Profit Margin for USNA's Competitors
EBITDA Margin Profit Margin for Usana Health Sciences Inc 's Suppliers
EBITDA Margin Profit Margin for USNA's Customers

You may also want to know
USNA's Annual Growth Rates USNA's Profitability Ratios USNA's Asset Turnover Ratio USNA's Dividend Growth
USNA's Roe USNA's Valuation Ratios USNA's Financial Strength Ratios USNA's EBITDA Growth
USNA's Roa USNA's Inventory Turnover Ratio USNA's Growth Rates USNA's Dividend Comparisons


Companies with similar EBITDA Margin in the quarter ending Dec 30 2023, within Legal Cannabis Industry EBITDA MarginDec 30 2023 MRQ EBITDADec 30 2023 MRQ Revenue
Usana Health Sciences Inc   13.38 %$ 29.668 $ 221.764 
Chromadex Corporation  2.89 %$ 0.612 $ 21.196 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com